| dc.description.abstract | Background. Coronavirus 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), an acute infectious disease primarily affecting the respiratory system. So far the data on exposure to COVID-19 during pregnancy and problems related to COVID-19 during pregnancy are limited. On that basis, the author intend to examine COVID-19 cases in pregnant women who were treated at RS USU during 2020-2022 to determine the effect of COVID-19 cases on Pregnancy at RS USU during 2020-2022. Purpose. This research aims to determine the number of pregnant women, findings from laboratory tests related to COVID-19 infection, infant outcomes, and referral characteristics for COVID-19 & non-COVID-19 pregnant women at RS USU during 2020 - 2022 period. Methods. This research was conducted using a descriptive method with a cross-sectional study approach using total sampling technique by collecting secondary data from COVID-19 and non-COVID-19 pregnant women at RS USU during 2020-2022 period, where 112 samples were obtained, then the results were analyzed by SPSS application. Results. Furthermore, it was found that the majority of pregnant women with COVID-19 and non-COVID-19 pregnant women were found successively based on Hb (11.6%-decreased vs 79.5%-normal); Ht (11.6%-decreased vs 76.8%-increased); leukocytes (11.6%-increased vs 83%-normal); thrombocytes (8.9%-normal vs 86.6%-normal); PT (9.8%-normal vs 50.9%-normal); APTT (11.6%-normal vs 87.5%-normal); D-dimer (11.6%-long vs 56.3%-long); procalcitonin (7.1%-increased vs 87.5%-normal); NLR (8%-increased vs 82.1%-normal); CRP (12.5%-increased vs 87.5%-normal) and all of the baby outcomes were non-COVID-19 and the majority of pregnant women were not referred. Conclusion. Based on the data in this study, the majority of pregnant women and babies at USU Hospital for the 2021-2022 period were non-COVID-19 with non-referral status. | en_US |
